Plasma Fractionation Market
PUBLISHED: 2023 ID: SMRC24460
SHARE
SHARE

Plasma Fractionation Market

Plasma Fractionation Market Forecasts to 2030 - Global Analysis By Product (Immunoglobulins, Albumin, Platelets & Coagulation Factor Concentrates, Protease Inhibitors and Other Products), Method, Application, End User and By Geography

4.2 (48 reviews)
4.2 (48 reviews)
Published: 2023 ID: SMRC24460

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2021-2030

Estimated Year Value (2023)

US $29.0 BN

Projected Year Value (2030)

US $46.2 BN

CAGR (2023 - 2030)

6.9%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

Asia Pacific

Highest Growing Market

North America


According to Stratistics MRC, the Global Plasma Fractionation Market is accounted for $29.0 billion in 2023 and is expected to reach $46.2 billion by 2030 growing at a CAGR of 6.9% during the forecast period. In order to create therapeutic products that can be utilized to treat a variety of medical diseases, blood plasma's constituent parts are separated through a procedure called plasma fractionation. The liquid portion of blood, known as blood plasma, includes proteins and other materials necessary for body operations. These proteins are separated and purified for use in medicine using plasma fractionation. A vital procedure that offers treatments that can save lives for a variety of illnesses is plasma fractionation. Nonetheless, to guarantee that the finished goods are risk-free, efficient, and devoid of impurities, stringent adherence to quality and safety requirements is necessary.

According to a research study published by Springer in January 2022, Acquired hemophilia A (AHA) is a severe acquired rare bleeding disorder with which only 1-1.5 per million persons are affected yearly.  

Market Dynamics: 

Driver: 

Increasing numbers of immunodeficiency disorders

Worldwide, there has been a noticeable increase in the demand for treatments produced from plasma. Strong demand for immunoglobulin contributed to the global market's good expansion. The increase in different immunodeficiency diseases instances worldwide is the cause of the increased demand. Immunoglobulin replacement or targeted immunoglobulin therapy are two possible treatments for these illnesses. Consequently, as the need for these therapies grows, so does the amount of immunoglobulin produced by these methods, which propels the market.

Restraint:

Emergence of gene-editing therapies

By specifically targeting genetic defects, gene-editing therapies provide novel approaches to treating diseases and may eventually eliminate the need for some plasma-derived therapies. The use of gene-editing therapies may lead to a drop in the market share and income for plasma fractionation companies as a result of a decrease in the demand for products produced from plasma. Businesses that depend significantly on plasma-derived treatments may face financial consequences in the event that treatment paradigms significantly shift in favour of gene editing thereby hampering the market.

Opportunity:

Rise in plasma collection facilities across the globe

An increased supply of plasma as the raw material for plasma fractionation could result from more collection facilities. This increase in plasma availability may have a beneficial effect on the ability to produce products derived from plasma, such as albumin, clotting factors, and immunoglobulins. The market for plasma fractionation may be impacted by the location and legal framework of plasma collection facilities. Moreover, regulations pertaining to safety requirements, plasma collection, and the import and export of goods obtained from plasma vary throughout nations. 

Threat:

Technological challenges 

Problems with technology, like antiquated or ineffective plasma fractionation methods, can cause processing times to increase and productivity to decrease. Lower yields of plasma-derived products could be the consequence of this inefficiency, which would restrict the amount available for distribution and possibly raise expenses. Scalability issues may arise with some outdated technology or processes, making it challenging to raise output levels to keep up with demand. Inadequate scalability can impede the growth of markets and cause shortages in supplies.

Covid-19 Impact

The demand for goods produced from plasma, especially immunoglobulins, surged as a result of COVID-19. For COVID-19 patients who are extremely sick, these antibodies were investigated as a possible therapy option. As a result, there was an increase in the need for plasma from COVID-19 survivors in order to create convalescent plasma and maybe create treatments involving hyper immune globulin. To handle issues brought on by the pandemic, regulatory bodies modified their rules and regulations, guaranteeing the security and availability of goods obtained from plasma. 

The immunoglobulins segment is expected to be the largest during the forecast period

The immunoglobulins segment is estimated to have a lucrative growth, as immunoglobulins are used to treat a range of illnesses, such as immune deficiencies, autoimmune disorders, and several neurological ailments. Intravenous immunoglobulin (IVIG) is a widely used substance that is derived from plasma fractionation and is used to treat a variety of illnesses and strengthen the immune system.  The effectiveness of isolating immunoglobulins and other plasma proteins has been enhanced by ongoing technological improvements in plasma fractionation procedures, improving product yields and quality.

The depth filtration segment is expected to have the highest CAGR during the forecast period

The depth filtration segment is anticipated to witness the highest CAGR growth during the forecast period, because depth filtration is a crucial step in the purification and separation of proteins, including immunoglobulins and other vital constituents. It is used as one of the main techniques to get high-purity protein products by eliminating contaminants. In order to capture and hold particles of different sizes and separate them from the required components according to their size, shape, and interaction with the filter material, this procedure depends on the depth of the filter matrix thus boosting the market.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period, owing to the presence of governmental authorities that oversee and control plasma collection, fractionation, and sales is a major element driving the market's growth, and as a result, Asia-Pacific offers important participants in the plasma fractionation industry lucrative potential. Furthermore, a sharp increase in the emphasis of top producers on regional expansion in developing Asia-Pacific nations in order to gain a larger market share is anticipated to propel the growth of the plasma fractionation industry.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the presence of key companies, growing research and development efforts related to plasma fractionation, and an aging population, the North American region is anticipated to occupy a sizable proportion of the market for plasma fractionation.  Furthermore, the expansion of plasma collecting facilities in the area as well as ongoing initiatives to increase the availability of plasma is anticipated to fuel market expansion. For example, in order to increase Canada's national blood plasma supply, Grifols SA and Canadian Blood Services (CBS) joined in September 2022.  Thus the growing geriatric population, rising healthcare spending, and rising initiatives from key market are propelling the market growth.

Key players in the market

Some of the key players profiled in the Plasma Fractionation Market include Grifols, S.A., Intas Pharmaceuticals Ltd., LFB, Takeda Pharmaceutical company limited, Octapharma AG, Sanquin, Emergent BioSolutions, Shanghai Raas Blood Products Co., Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Kamada, Centurion Pharma, Virchow Biotech Private Limited, Fusion Healthcare, Hemarus Therapeutics Limited, Hualan Bioengineering Co., Ltd., China Biologic Products Holdings Inc., ADMA Biologics, CSL, Baxter International Inc and Bio Products Laboratory

Key Developments:

In December 2023, Emergent BioSolutions Announces Initiation of Phase 1 Study Evaluating Its Universal Influenza Vaccine Candidate. This current version of Emergent’s universal influenza vaccine candidate contains multiple components intended to induce broad.

In October 2023, Baxter Launches Digital Image Capture Capability for PanOptic Plus Ophthalmoscope, the iExaminer Pro System adds a key technology to routine eye exams, designed.

In July 2023, Kamada Announces Kedrion Exercised its Option for Two-Year Extension of KEDRAB® Distribution Agreement in the U.S. The Company Generated Approximately $16 Million in Revenue from Sales of KEDRAB to Kedrion in 2022 and Anticipates a Significant Increase in 2023

Products Covered:
• Immunoglobulins
• Albumin
• Platelets & Coagulation Factor Concentrates
• Protease Inhibitors
• Other Products
         
Methods Covered:
• Depth Filtration
• Chromatography
• Centrifugation

Applications Covered:
• Immunology
• Neurology
• Critical Care
• Hematology
• Rheumatology
• Hemato-Oncology
• Pulmonology
• Other Applications

End Users Covered:
• Clinical Research Laboratories
• Hospitals & Clinics
• Academic Institutes
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary     
       
2 Preface      
 2.1 Abstract     
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology   
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions   
       
3 Market Trend Analysis    
 3.1 Introduction    
 3.2 Drivers     
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats     
 3.6 Product Analysis    
 3.7 Application Analysis   
 3.8 End User Analysis    
 3.9 Emerging Markets    
 3.10 Impact of Covid-19    
       
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes   
 4.4 Threat of new entrants   
 4.5 Competitive rivalry    
       
5 Global Plasma Fractionation Market, By Product  
 5.1 Introduction    
 5.2 Immunoglobulins    
  5.2.1 Subcutaneous Immunoglobulin 
  5.2.2 Intravenous Immunoglobulin  
 5.3 Albumin     
 5.4 Platelets & Coagulation Factor Concentrates 
  5.4.1 Factor VIII   
  5.4.2 Factor IX    
  5.4.3 Von Willebrand Factor  
  5.4.4 Fibrinogen Concentrates  
  5.4.5 Prothrombin Complex Concentrates 
  5.4.6 Factor XIII   
  5.4.7 Other Platelets & Coagulation Factor Concentrates
 5.5 Protease Inhibitors    
 5.6 Other Products    
       
6 Global Plasma Fractionation Market, By Method  
 6.1 Introduction    
 6.2 Depth Filtration    
 6.3 Chromatography    
 6.4 Centrifugation    
       
7 Global Plasma Fractionation Market, By Application 
 7.1 Introduction    
 7.2 Immunology    
 7.3 Neurology    
 7.4 Critical Care    
 7.5 Hematology    
 7.6 Rheumatology    
 7.7 Hemato-Oncology    
 7.8 Pulmonology    
 7.9 Other Applications    
       
8 Global Plasma Fractionation Market, By End User  
 8.1 Introduction    
 8.2 Clinical Research Laboratories   
 8.3 Hospitals & Clinics    
 8.4 Academic Institutes    
 8.5 Other End Users    
       
9 Global Plasma Fractionation Market, By Geography  
 9.1 Introduction    
 9.2 North America    
  9.2.1 US    
  9.2.2 Canada    
  9.2.3 Mexico    
 9.3 Europe     
  9.3.1 Germany    
  9.3.2 UK    
  9.3.3 Italy    
  9.3.4 France    
  9.3.5 Spain    
  9.3.6 Rest of Europe   
 9.4 Asia Pacific    
  9.4.1 Japan    
  9.4.2 China    
  9.4.3 India    
  9.4.4 Australia    
  9.4.5 New Zealand   
  9.4.6 South Korea   
  9.4.7 Rest of Asia Pacific   
 9.5 South America    
  9.5.1 Argentina   
  9.5.2 Brazil    
  9.5.3 Chile    
  9.5.4 Rest of South America  
 9.6 Middle East & Africa   
  9.6.1 Saudi Arabia   
  9.6.2 UAE    
  9.6.3 Qatar    
  9.6.4 South Africa   
  9.6.5 Rest of Middle East & Africa  
       
10 Key Developments     
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
 10.2 Acquisitions & Mergers   
 10.3 New Product Launch   
 10.4 Expansions    
 10.5 Other Key Strategies   
       
11 Company Profiling     
 11.1 Grifols, S.A.    
 11.2 Intas Pharmaceuticals Ltd.   
 11.3 LFB      
 11.4 Takeda Pharmaceutical company limited  
 11.5 Octapharma AG    
 11.6 Sanquin      
 11.7 Emergent BioSolutions   
 11.8 Shanghai Raas Blood Products Co., Ltd.  
 11.9 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. 
 11.10 Kamada      
 11.11 Centurion Pharma    
 11.12 Virchow Biotech Private Limited  
 11.13 Fusion Healthcare    
 11.14 Hemarus Therapeutics Limited  
 11.15 Hualan Bioengineering Co., Ltd.   
 11.16 China Biologic Products Holdings Inc.  
 11.17 ADMA Biologics    
 11.18 CSL      
 11.19 Baxter International Inc   
 11.20 Bio Products Laboratory    
       
List of Tables      
1 Global Plasma Fractionation Market Outlook, By Region (2021-2030) ($MN)
2 Global Plasma Fractionation Market Outlook, By Product (2021-2030) ($MN)
3 Global Plasma Fractionation Market Outlook, By Immunoglobulins (2021-2030) ($MN)
4 Global Plasma Fractionation Market Outlook, By Subcutaneous Immunoglobulin (2021-2030) ($MN)
5 Global Plasma Fractionation Market Outlook, By Intravenous Immunoglobulin (2021-2030) ($MN)
6 Global Plasma Fractionation Market Outlook, By Albumin (2021-2030) ($MN)
7 Global Plasma Fractionation Market Outlook, By Platelets & Coagulation Factor Concentrates (2021-2030) ($MN)
8 Global Plasma Fractionation Market Outlook, By Factor VIII (2021-2030) ($MN)
9 Global Plasma Fractionation Market Outlook, By Factor IX (2021-2030) ($MN)
10 Global Plasma Fractionation Market Outlook, By Von Willebrand Factor (2021-2030) ($MN)
11 Global Plasma Fractionation Market Outlook, By Fibrinogen Concentrates (2021-2030) ($MN)
12 Global Plasma Fractionation Market Outlook, By Prothrombin Complex Concentrates (2021-2030) ($MN)
13 Global Plasma Fractionation Market Outlook, By Factor XIII (2021-2030) ($MN)
14 Global Plasma Fractionation Market Outlook, By Other Platelets & Coagulation Factor Concentrates (2021-2030) ($MN)
15 Global Plasma Fractionation Market Outlook, By Protease Inhibitors (2021-2030) ($MN)
16 Global Plasma Fractionation Market Outlook, By Other Products (2021-2030) ($MN)
17 Global Plasma Fractionation Market Outlook, By Method (2021-2030) ($MN)
18 Global Plasma Fractionation Market Outlook, By Depth Filtration (2021-2030) ($MN)
19 Global Plasma Fractionation Market Outlook, By Chromatography (2021-2030) ($MN)
20 Global Plasma Fractionation Market Outlook, By Centrifugation (2021-2030) ($MN)
21 Global Plasma Fractionation Market Outlook, By Application (2021-2030) ($MN)
22 Global Plasma Fractionation Market Outlook, By Immunology (2021-2030) ($MN)
23 Global Plasma Fractionation Market Outlook, By Neurology (2021-2030) ($MN)
24 Global Plasma Fractionation Market Outlook, By Critical Care (2021-2030) ($MN)
25 Global Plasma Fractionation Market Outlook, By Hematology (2021-2030) ($MN)
26 Global Plasma Fractionation Market Outlook, By Rheumatology (2021-2030) ($MN)
27 Global Plasma Fractionation Market Outlook, By Hemato-Oncology (2021-2030) ($MN)
28 Global Plasma Fractionation Market Outlook, By Pulmonology (2021-2030) ($MN)
29 Global Plasma Fractionation Market Outlook, By Other Applications (2021-2030) ($MN)
30 Global Plasma Fractionation Market Outlook, By End User (2021-2030) ($MN)
31 Global Plasma Fractionation Market Outlook, By Clinical Research Laboratories (2021-2030) ($MN)
32 Global Plasma Fractionation Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
33 Global Plasma Fractionation Market Outlook, By Academic Institutes (2021-2030) ($MN)
34 Global Plasma Fractionation Market Outlook, By Other End Users (2021-2030) ($MN)
       
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials